Join
Live feed
·
INSIDERFilingvia Quantisnow
Quoin Pharmaceuticals Ltd. logo

Director Culverwell Anthony James was granted 31,352 units of ADSs, increasing direct ownership by 1,094% to 34,218 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNRX (Quoin Pharmaceuticals Ltd.) and more on Quantisnow.